- ‘We plan to bring out innovative tailor-made cells for diseases’ - Hindu
- ‘We have a $20-m R&D budget for pure drug discovery’ - Hindu Business Line
- Ranbaxy R&D spin-off - Hindu Business Line
- ‘The nutraceutical industry is at varying levels of maturity’ - Hindu Business Line
- Biocon Q4 net up 7.6% on biopharma, contract research - Hindu Business Line
‘We plan to bring out innovative tailor-made cells for diseases’ - Hindu Business Line
Hindu Business Line‘We plan to bring out innovative tailor-made cells for diseases’Hindu Business Line, India - 7 hours agoIndia is lagging behind on research and clinical trials compared to other countries. Very few patents (less than 10) and no Drug Controller General of India ...
